Literature DB >> 26231738

Fabrication of a BMP-2-immobilized porous microsphere modified by heparin for bone tissue engineering.

Sung Eun Kim1, Young-Pil Yun1, Kyu-Sik Shim2, Kyeongsoon Park3, Sung-Wook Choi4, Dong Hyup Shin5, Dong Hun Suh6.   

Abstract

The purpose of this study was to fabricate BMP-2-immobilized porous poly(lactide-co-glycolide) (PLGA) microspheres (PMS) modified with heparin for bone regeneration. A fluidic device was used to fabricate PMS and the fabricated PMS was modified with heparin-dopamine (Hep-DOPA). Bone morphogenic protein-2 (BMP-2) was immobilized on the heparinized PMS (Hep-PMS) via electrostatic interactions. Both PMS and modified PMS were characterized using scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS). MG-63 cell activity on PMS and modified PMS were assessed via alkaline phosphatase (ALP) activity, calcium deposition, and osteocalcin and osteopontin mRNA expression. Immobilized Hep-DOPA and BMP-2 on PMS were demonstrated by XPS analysis. BMP-2-immobilized Hep-PMS provided significantly higher ALP activity, calcium deposition, and osteocalcin and osteopontin mRNA expression compared to PMS alone. These results suggest that BMP-2-immobilized Hep-PMS effectively improves MG-63 cell activity. In conclusion, BMP-2-immobilized Hep-PMS can be used to effectively regenerate bone defects.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone morphogenic protein-2 (BMP-2); Bone tissue engineering; Fluidic device; Heparin; Porous microspheres

Mesh:

Year:  2015        PMID: 26231738     DOI: 10.1016/j.colsurfb.2015.05.003

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  8 in total

Review 1.  The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials.

Authors:  Jing Wang; Lan Xiao; Weiqun Wang; Dingmei Zhang; Yaping Ma; Yi Zhang; Xin Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-12

2.  In vitro cell delivery by gelatin microspheres prepared in water-in-oil emulsion.

Authors:  Nicola Contessi Negrini; Maria Veronica Lipreri; Maria Cristina Tanzi; Silvia Farè
Journal:  J Mater Sci Mater Med       Date:  2020-02-14       Impact factor: 3.896

3.  Heparin-functionalized polymer graft surface eluting MK2 inhibitory peptide to improve hemocompatibility and anti-neointimal activity.

Authors:  Yunki Lee; Phuong Le Thi; Gyeung Mi Seon; Seung Bae Ryu; Colleen M Brophy; YongTae Kim; Jong-Chul Park; Ki Dong Park; Joyce Cheung-Flynn; Hak-Joon Sung
Journal:  J Control Release       Date:  2017-10-04       Impact factor: 9.776

Review 4.  Biomaterials for the Treatment of Tendon Injury.

Authors:  Sung Eun Kim; Jae Gyoon Kim; Kyeongsoon Park
Journal:  Tissue Eng Regen Med       Date:  2019-09-13       Impact factor: 4.169

5.  Exploring the In Vivo Anti-Inflammatory Actions of Simvastatin-Loaded Porous Microspheres on Inflamed Tenocytes in a Collagenase-Induced Animal Model of Achilles Tendinitis.

Authors:  Chandong Jeong; Sung Eun Kim; Kyu-Sik Shim; Hak-Jun Kim; Mi Hyun Song; Kyeongsoon Park; Hae-Ryong Song
Journal:  Int J Mol Sci       Date:  2018-03-12       Impact factor: 5.923

6.  Design of a 3D BMP-2-Delivering Tannylated PCL Scaffold and Its Anti-Oxidant, Anti-Inflammatory, and Osteogenic Effects In Vitro.

Authors:  Jae Yong Lee; Hyunwoong Lim; Jae Won Ahn; Dongsik Jang; Seung Hee Lee; Kyeongsoon Park; Sung Eun Kim
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

7.  The preosteoblast response of electrospinning PLGA/PCL nanofibers: effects of biomimetic architecture and collagen I.

Authors:  Yunzhu Qian; Hanbang Chen; Yang Xu; Jianxin Yang; Xuefeng Zhou; Feimin Zhang; Ning Gu
Journal:  Int J Nanomedicine       Date:  2016-08-25

8.  Bone Morphogenic Protein-2 (rhBMP2)-Loaded Silk Fibroin Scaffolds to Enhance the Osteoinductivity in Bone Tissue Engineering.

Authors:  Guang-Yu Du; Sheng-Wei He; Chuan-Xiu Sun; Li-Dong Mi
Journal:  Nanoscale Res Lett       Date:  2017-10-25       Impact factor: 4.703

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.